CLS Health Cardiologists Achieve Historic First with Transcarotid TAVR in Southeast Houston

The cutting-edge procedure that avoids open-heart surgery is momentous in cardiac care

HOUSTON, TX / ACCESSWIRE / March 14, 2024 / In a groundbreaking medical advancement, three esteemed cardiologists from CLS Health, Dr. Bahaeddin Shabaneh, Dr. Fethi Benraouane, and Dr. Molham Aldeiri, have successfully performed the first series of transcarotid Transcatheter Aortic Valve Replacement (TAVR) procedures ever done in Southeast Houston. This innovative approach, which involves replacing a diseased aortic valve through a small neck incision without the need for open-heart surgery, marks a significant leap forward in cardiac care.

In the photo from left to right are Dr. Fethi Benraouane (CLS Health), Dr. Molham Aldeiri (CLS Health), Dr. Bahaeddin Shabaneh (CLS Health), Dr. Dan Logsdon (CT surgeon), Dr. Hannan Chaugle (CT surgeon).

TAVR, whether through the groin approach or neck approach, only requires a half-inch or inch incision. It is increasingly overtaking surgical valve replacement through open heart surgery in patients 65 years or older, as it may achieve comparable results without opening the patient’s chest.

The TAVR surgery is a minimally invasive technique performed under local anesthesia with sedation that provides hope for patients who are ineligible for the conventional femoral artery approach. The unique aspect of the carotid approach is done by making a small incision in the neck to deliver the aortic valve in patients who cannot have it through the femoral artery in the groin, which is the standard approach. This novel approach potentially decreases the risk of stroke and vascular complications and makes more options available for patients.

CLS Health cardiologists Dr. Bahaeddin Shabaneh, Dr. Fethi Benraouane, Dr. Molham Aldeiri, and Dr. Ahmad Al-Taweel collectively have performed the highest number of TAVR procedures in Southeast Houston, and a sizable portion of the 600+ procedures done at hospitals in the area (HCA Houston Healthcare Clear Lake, Memorial Herman Southeast), compared to other cardiologists and groups in the area.

CLS Health is committed to delivering exemplary care through innovative procedures, ensuring patients in Southeast Houston and beyond have access to the best possible cardiac treatments.

About CLS Health:
CLS Health is a physician-owned healthcare group with a pioneering approach to comprehensive care. With over 33 locations and 160+ providers in the Greater Houston area, CLS Health emphasizes the satisfaction and empowerment of its physicians as a key element in delivering exceptional patient care. To learn more, visit cls.health.

Contact Information

Isaiah Rincon
Media Relations Manager
bd@cls.health
832-557-3338

Maria Penaloza
maria.penaloza@newswire.com

SOURCE: CLS Health

View the original press release on newswire.com.

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

17 minutes ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

18 minutes ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

21 minutes ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

21 minutes ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

21 minutes ago

Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson’s Disease

MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…

21 minutes ago